These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38906565)

  • 41. Left ventricular hypertrophy in the dialysed patient. What can be done about it?
    Cannella G
    Nephrol Dial Transplant; 1996 Mar; 11(3):418-20. PubMed ID: 8671807
    [No Abstract]   [Full Text] [Related]  

  • 42. [THE EFFECTIVENESS OF THE CORRECTION OF ENDOTHELIAL DYSFUNCTION AND REMODELING OF THE BRACHIAL ARTERY WITH CONCENTRIC AND ECCENTRIC LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH UNSTABLE ANGINA WITH COMORBID HYPERTENSION].
    Denesiuk EV
    Lik Sprava; 2015; (5-6):72-6. PubMed ID: 27089719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of meta-analyses of therapeutic studies on regression of left ventricular hypertrophy.
    Hansson L
    Adv Exp Med Biol; 1997; 432():189-90. PubMed ID: 9433525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of diastolic dysfunction in hypertensive left ventricular hypertrophy.
    Bella JN
    Am J Hypertens; 2006 Sep; 19(9):937-8. PubMed ID: 16942936
    [No Abstract]   [Full Text] [Related]  

  • 48. Current issues in hypertension research and therapy.
    MacFadyen RJ; Prasad N
    Br J Hosp Med; 1995 Apr 5-18; 53(7):335-43. PubMed ID: 7788073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E; Reid C; Qi XL; Jennings GL
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of regression of left ventricular hypertrophy on cardiac function in hypertension.
    Omotoso AB; Dunn FG
    Eur Heart J; 1992 Sep; 13 Suppl D():107-10. PubMed ID: 1396853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of recent papers in hypertension.
    Bloch MJ; Basile JN
    J Clin Hypertens (Greenwich); 2007 May; 9(5):396. PubMed ID: 17546794
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension and coronary microvascular disease.
    Strauer BE; Schwartzkopff B
    Adv Exp Med Biol; 1997; 432():207-13. PubMed ID: 9433528
    [No Abstract]   [Full Text] [Related]  

  • 59. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
    Clement DL; De Buyzere M; Duprez D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Blood pressure monitoring in left ventricular hypertrophy].
    Kraft K
    Internist (Berl); 1997 Jun; 38(6):616. PubMed ID: 9265010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.